These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 17919562)

  • 1. Early breast cancer therapy and cardiovascular injury.
    Jones LW; Haykowsky MJ; Swartz JJ; Douglas PS; Mackey JR
    J Am Coll Cardiol; 2007 Oct; 50(15):1435-41. PubMed ID: 17919562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early-stage breast cancer - strategies for adjuvant systemic therapy].
    Görner M; Just M; Gerull S
    Handchir Mikrochir Plast Chir; 2008 Aug; 40(4):230-8. PubMed ID: 18716990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897.
    Ganz PA; Hussey MA; Moinpour CM; Unger JM; Hutchins LF; Dakhil SR; Giguere JK; Goodwin JW; Martino S; Albain KS
    J Clin Oncol; 2008 Mar; 26(8):1223-30. PubMed ID: 18227530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivorship and complications of treatment in breast cancer.
    Mrozek E; Shapiro CL
    Clin Adv Hematol Oncol; 2005 Mar; 3(3):211-22, 238. PubMed ID: 16166992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late cardiac effects of adjuvant radiotherapy and chemotherapy in early breast cancer.
    Coccaro M; Gallucci G
    J Clin Oncol; 2008 Jul; 26(19):3288; author reply 3289. PubMed ID: 18591567
    [No Abstract]   [Full Text] [Related]  

  • 6. Quality of life and adjuvant systemic therapy for early-stage breast cancer.
    Grimison PS; Stockler MR
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1123-34. PubMed ID: 18028021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy insight: Management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy.
    Khakoo AY; Yeh ET
    Nat Clin Pract Oncol; 2008 Nov; 5(11):655-67. PubMed ID: 18797437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular reserve and risk profile of postmenopausal women after chemoendocrine therapy for hormone receptor--positive operable breast cancer.
    Jones LW; Haykowsky M; Pituskin EN; Jendzjowsky NG; Tomczak CR; Haennel RG; Mackey JR
    Oncologist; 2007 Oct; 12(10):1156-64. PubMed ID: 17962609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors.
    Schmitz KH; Prosnitz RG; Schwartz AL; Carver JR
    Cancer; 2012 Apr; 118(8 Suppl):2270-6. PubMed ID: 22488701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A woman's heart: the impact of adjuvant endocrine therapy on cardiovascular health.
    Ewer MS; Glück S
    Cancer; 2009 May; 115(9):1813-26. PubMed ID: 19235248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
    Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
    Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological therapy of breast cancer: recent clinical applications.
    Baar J
    Curr Opin Investig Drugs; 2007 Dec; 8(12):987-95. PubMed ID: 18058569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectively nursing patients receiving aromatase inhibitor therapy.
    Wengström Y
    Breast; 2008 Jun; 17(3):227-38. PubMed ID: 18077168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of fertility and the impact of subsequent pregnancy in patients with premenopausal breast cancer.
    Park M; Davidson R; Fox K
    Semin Oncol; 2006 Dec; 33(6):664-71. PubMed ID: 17145346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse bone effects during pharmacological breast cancer therapy.
    Bjarnason NH; Hitz M; Jorgensen NR; Vestergaard P
    Acta Oncol; 2008; 47(4):747-54. PubMed ID: 18465344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?
    Tang SC
    Cancer Invest; 2008 Jun; 26(5):481-90. PubMed ID: 18568770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimising care of elderly breast cancer patients: a challenging priority.
    Tipples K; Robinson A
    Clin Oncol (R Coll Radiol); 2009 Mar; 21(2):118-30. PubMed ID: 19111450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Breast cancer in young women: epidemiology and treatment dilemmas].
    van der Sangen MJ; Voogd AC; van de Poll-Franse LV; Tjan-Heijnen VC
    Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2495-500. PubMed ID: 19055255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving quality of life after breast cancer: prevention of other diseases.
    Rozenberg S; Antoine C; Carly B; Pastijn A; Liebens F
    Menopause Int; 2007 Jun; 13(2):71-4. PubMed ID: 17540137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal trends in the use of adjuvant systemic therapy in breast cancer: a population based study in Sweden 1976-2005.
    Kemetli L; Rutqvist LE; Jonsson H; Nyström L; Lenner P; Törnberg S
    Acta Oncol; 2009; 48(1):59-66. PubMed ID: 18752084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.